Companies Mentioned

Ranbaxy Laboratories Limited

Category
Title
Summary
Date
Summaries
Patent Law >
New Settlements and Verdicts

Pfizer and Ranbaxy Settle Lipitor Patent Litigation Worldwide
The Lipitor patents involved in the settlement agreement are the basic compound patent, which expires in the United States in 2010; the enantiomer patent, which expires in the United States in 2011; as well as various process and crystalline form patents, which expire in 2016 and 2017; and the combination…
Date of ruling:
06/18/2008